CMETICKER
Cme Group Inc.
Congress has disclosed 29 buys and 25 sells of CME (Cme Group Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
29
Buy
25
Sell
+4
Net
21
Active politicians
Round-trip watch Still on the books
Members who disclosed buying CME and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Alan Armstrong | 2026-03-27 | $290.90 | $303.14 | +4.2% | ↩ near entry |
| Rob Bresnahan | 2025-04-08 | $243.22 | $303.14 | +24.6% | in profit |
| Carol Devine Miller | 2025-03-10 | $250.13 | $303.14 | +21.2% | in profit |
| Rohit Khanna | 2025-11-03 | $254.29 | $303.14 | +19.2% | in profit |
Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Price & congressional trades
Buy
Sell
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Finance. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
P/E
26.25
▲ pricier than
Finance (median 17.2)
how it's calculated
P/E = price ÷ earnings per share
$303.14 ÷ $11.55 = 26.25
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
4.12
▲ pricier than
Finance (median 1.8)
how it's calculated
P/B = price ÷ book value per share
$303.14 ÷ $73.57 = 4.12
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
EV/EBITDA
22.89
▲ pricier than
Finance (median 16.3)
how it's calculated
EV/EBITDA = (market cap + net debt) ÷ EBITDA — net cash lowers EV
($109.4B − $2.2B net cash) ÷ $4.7B = $107.2B ÷ $4.7B = 22.89
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
Legislation Related Legislation
Recent bills in this stock's sector (Finance). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.
| Bill | Title | Policy area | Latest action |
|---|---|---|---|
| HR 10820 | Epstein Wall Street Records Act of 2026 | Finance and Financial Sector | 2026-10-15 |
| HR 10821 | To amend the Federal Deposit Insurance Act to make changes to the Standard Maximum Deposit Insurance Amount, and for other purposes. | Finance and Financial Sector | 2026-10-15 |
| S 4395 | Terrorism Risk Insurance Program Reauthorization Act of 2026 | Finance and Financial Sector | 2026-10-05 |
| S 1564 | Floodplain Enhancement and Recovery Act | Finance and Financial Sector | 2026-10-05 |
| S 5644 | A bill to amend title 31, United States Code, to exempt transactions with respect to cash reward payments by crime stopper organizations from certain currency transaction reports. | Finance and Financial Sector | 2026-09-30 |
54 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Gilbert Cisneros | House | SELL ◆ insider divergence · moderate | Self · 150 Main Street Trust > Bank of America | 2026-06-16 | 16 days | -9.6% | $1K–$15K 0.1% of NW |
47.1 | ↗ filing |
| Alan Armstrong | Senate | BUY ◆ insider convergence · moderate | Self | 2026-03-27 | 116 days | -18.8% | $1K–$15K | 82.9 | ↗ eFD |
| Gilbert Cisneros | House | BUY ◆ insider convergence · moderate | Self · 150 Main Street Trust > Bank of America | 2026-01-09 | 33 days | +15.3% | $1K–$15K 0.1% of NW |
64.2 | ↗ filing |
| Julie Johnson | House | SELL ◆ insider convergence · moderate | Joint · Chase Brokerage Account (3935) | 2025-12-18 | 18 days | +3.4% | $1K–$15K <0.1% of NW |
5.0 | ↗ filing |
| Julie Johnson | House | SELL ◆ insider convergence · moderate | Joint · Chase Brokerage Account (3935) | 2025-11-13 | 22 days | -4.5% | $1K–$15K <0.1% of NW |
7.6 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence · moderate | Child | 2025-11-03 | 31 days | +3.4% | $1K–$15K | 11.6 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence · moderate | Child | 2025-09-29 | 3 days | -2.5% | $1K–$15K | 17.1 | ↗ filing |
| Valerie Hoyle | House | SELL ◆ insider convergence · moderate | Spouse · Fidelity Rollover IRA | 2025-09-23 | 0 days | 0.0% | $1K–$15K 0.8% of NW |
30.3 | ↗ filing |
| Julie Johnson | House | SELL ◆ insider divergence · moderate | Joint · Chase Brokerage Account (3935) | 2025-08-14 | 19 days | -3.4% | $1K–$15K <0.1% of NW |
13.1 | ↗ filing |
| Julie Johnson | House | BUY ◆ insider convergence · moderate | Joint · Chase Brokerage Account (3935) | 2025-08-11 | 22 days | -7.1% | $1K–$15K <0.1% of NW |
27.1 | ↗ filing |
| Julie Johnson | House | BUY ◆ insider convergence · moderate | Joint · Chase Brokerage Account (3935) | 2025-07-22 | 13 days | +4.5% | $1K–$15K <0.1% of NW |
62.7 | ↗ filing |
| Valerie Hoyle | House | BUY ◆ insider convergence · moderate | Spouse · Fidelity Rollover IRA | 2025-05-21 | 113 days | -6.0% | $1K–$15K 0.8% of NW |
65.6 | ↗ filing |
| Rob Bresnahan | House | BUY ◆ insider convergence · moderate | Self · JP Morgan Brokerage Account | 2025-04-08 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
67.0 | ↗ filing |
| Carol Devine Miller | House | BUY ◆ insider convergence · moderate | Self · Matt Miller Investment Management Account | 2025-03-10 | 32 days | -0.3% | $1K–$15K <0.1% of NW |
98.1 | ↗ filing |
| John James | House | SELL ◆ insider convergence · moderate | Self · John A. James Children’s Trust | 2024-09-04 | 1 days | +1.6% | $1K–$15K <0.1% of NW |
26.0 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence · moderate | Child | 2024-08-05 | 31 days | — | $1K–$15K | 22.3 | ↗ filing |
| Kathy Manning | House | SELL ◆ insider convergence · moderate | Spouse · Kathy Manning GST FBO Randall Kaplan > ManKap Family LLC > MV Capital - Brokerage #2 | 2024-07-02 | 43 days | — | $1K–$15K 0.1% of NW |
0.5 | ↗ filing |
| Kathy Manning | House | SELL ◆ insider convergence · moderate | Spouse · MV Capital - GST Exempt Trust #2 | 2024-07-02 | 43 days | — | $1K–$15K 0.1% of NW |
0.5 | ↗ filing |
| Kathy Manning | House | BUY ◆ insider convergence · moderate | Spouse · Kathy Manning GST FBO Randall Kaplan > ManKap Family LLC > MV Capital - Brokerage #2 | 2024-01-23 | 10 days | — | $1K–$15K 0.1% of NW |
7.3 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence · moderate | Child | 2024-01-10 | 23 days | — | $1K–$15K | 52.4 | ↗ filing |
| Michael Burgess | House | SELL ◆ insider convergence · moderate | Self | 2023-12-06 | 2 days | — | $15K–$50K 0.7% of NW |
56.6 | ↗ filing |
| John James | House | BUY ◆ insider convergence · moderate | Self · John A. James Children’s Trust | 2023-11-10 | 277 days | — | $1K–$15K <0.1% of NW |
75.9 | ↗ filing |
| Michael Burgess | House | BUY ◆ insider convergence · moderate | Self | 2023-08-09 | 2 days | — | $15K–$50K 0.7% of NW |
90.9 | ↗ filing |
| Zoe Lofgren | House | SELL ◆ insider divergence · moderate | Spouse · John Marshall Collins Rollover IRA | 2023-05-25 | 12 days | — | $1K–$15K 0.1% of NW |
15.7 | ↗ filing |
| Daniel Goldman | House | BUY ◆ insider convergence · moderate | Self · Daniel Goldman Grandchildren 1986 Trust > TACS R3K | 2023-01-31 | 9 days | — | $1K–$15K <0.1% of NW |
86.8 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence · moderate | Child | 2023-01-11 | 22 days | — | $1K–$15K | 86.8 | ↗ filing |
| Kathy Manning | House | BUY | Spouse · The 2011 Randall R. Kaplan Living Trust > MV Capital - Brokerage #2 | 2022-07-27 | 6 days | — | $1K–$15K 0.1% of NW |
6.8 | ↗ filing |
| Kathy Manning | House | SELL | Joint · Charles Schwab - Edgewood Management LLC C: Remaining shares transferred to a Donor Advised Fund | 2022-06-10 | 25 days | — | $15K–$50K 0.3% of NW |
25.4 | ↗ filing |
| Kathy Manning | House | SELL | Joint · Charles Schwab - Edgewood Management LLC | 2022-05-27 | 10 days | — | $1K–$15K 0.1% of NW |
10.6 | ↗ filing |
| Kathy Manning | House | SELL | Joint | 2022-03-03 | 32 days | — | $1K–$15K 0.1% of NW |
15.7 | ↗ filing |
| Robert Wittman | House | SELL | Self | 2021-12-14 | 2 days | — | $1K–$15K 0.2% of NW |
75.9 | ↗ filing |
| Kathy Manning | House | BUY | Joint | 2021-11-05 | 96 days | — | $1K–$15K 0.1% of NW |
22.3 | ↗ filing |
| Zoe Lofgren | House | BUY | Joint | 2021-09-02 | 35 days | — | $1K–$15K 0.1% of NW |
22.3 | ↗ filing |
| John Curtis | House | SELL | Self | 2021-06-22 | 9 days | — | $1K–$15K | 40.4 | ↗ filing |
| Kathy Manning | House | BUY | Joint | 2021-03-08 | 338 days | — | $1K–$15K 0.1% of NW |
40.4 | ↗ filing |
| Kathy Manning | House | BUY | Self | 2021-01-15 | 18 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Dean Phillips | House | BUY | Self | 2020-09-23 | 14 days | — | $1K–$15K <0.1% of NW |
75.9 | ↗ filing |
| Donald Sternoff Beyer | House | SELL | Joint | 2020-07-10 | 22 days | — | $1K–$15K <0.1% of NW |
86.8 | ↗ filing |
| John Yarmuth | House | SELL | Self | 2020-07-01 | 41 days | — | $1K–$15K | 31.8 | ↗ filing |
| John Yarmuth | House | SELL | Self | 2020-06-08 | 31 days | — | $1K–$15K | 40.4 | ↗ filing |
| John Curtis | House | BUY | Self | 2020-03-27 | 0 days | — | $1K–$15K | 75.9 | ↗ filing |
| Zoe Lofgren | House | SELL | Spouse | 2020-03-23 | 0 days | — | $1K–$15K 0.1% of NW |
40.4 | ↗ filing |
| Mikie Sherrill | House | SELL | Self | 2020-02-20 | 12 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Donald Sternoff Beyer | House | BUY | Joint | 2020-02-19 | 3 days | — | $1K–$15K <0.1% of NW |
84.3 | ↗ filing |
| Donald Sternoff Beyer | House | BUY | Joint | 2019-12-10 | 4 days | — | $1K–$15K <0.1% of NW |
88.5 | ↗ filing |
| Donald Sternoff Beyer | House | BUY | Joint | 2019-11-26 | 10 days | — | $1K–$15K <0.1% of NW |
94.6 | ↗ filing |
| Donald Sternoff Beyer | House | BUY | Joint | 2019-11-19 | 17 days | — | $1K–$15K <0.1% of NW |
98.8 | ↗ filing |
| John Yarmuth | House | BUY | Self | 2017-09-20 | 21 days | — | $1K–$15K | 75.9 | ↗ filing |
| Zoe Lofgren | House | BUY | Spouse | 2017-06-15 | 27 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Thomas Suozzi | House | SELL | Self | 2017-01-05 | 25 days | — | $1K–$15K 0.1% of NW |
98.8 | ↗ filing |
| Thomas Suozzi | House | SELL | Self · Charles Schwab Retirement Account | 2017-01-05 | 25 days | — | $1K–$15K 0.1% of NW |
98.8 | ↗ filing |
| Lois Frankel | House | SELL | Self | 2014-06-12 | 0 days | — | $1K–$15K 0.3% of NW |
75.9 | ↗ filing |
| Katherine Clark | House | SELL | Self | 2014-03-13 | 252 days | — | $1K–$15K 0.1% of NW |
40.4 | ↗ filing |
| Katherine Clark | House | SELL | Self | 2014-02-27 | 266 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in CME — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
23
Congress trades with insider convergence
3
…with insider divergence
132
Insider open-market trades
Of the congressional trades in CME, 23 coincided with corporate insiders moving the same way within 60 days, and 3 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-11-02 | Winkler Julie | C-suite | SELL | $3.1M | ↗ EDGAR |
| 2026-11-02 | SIEGEL HOWARD J | Director | SELL | $606K | ↗ EDGAR |
| 2026-10-27 | Cutinho Sunil | C-suite | SELL | $1.5M | ↗ EDGAR |
| 2026-10-22 | GEPSMAN MARTIN J | Director | SELL | $121K | ↗ EDGAR |
| 2026-09-25 | SHEPARD WILLIAM R | Director | BUY | $79K | ↗ EDGAR |
| 2026-09-14 | Cook Elizabeth A | Director | SELL | $140K | ↗ EDGAR |
| 2026-09-10 | DUFFY TERRENCE A | C-suite | SELL | $3.9M | ↗ EDGAR |
| 2026-09-10 | DUFFY TERRENCE A | C-suite | SELL | $173K | ↗ EDGAR |
| 2026-06-25 | SHEPARD WILLIAM R | Director | BUY | $3K | ↗ EDGAR |
| 2026-06-25 | SHEPARD WILLIAM R | Director | BUY | $75K | ↗ EDGAR |
| 2026-05-18 | Piell Hilda Harris | C-suite | SELL | $1.8M | ↗ EDGAR |
| 2026-05-15 | DUFFY TERRENCE A | C-suite | SELL | $7.8M | ↗ EDGAR |
| 2026-05-15 | DUFFY TERRENCE A | C-suite | SELL | $2.7M | ↗ EDGAR |
| 2026-03-26 | SHEPARD WILLIAM R | Director | BUY | $419K | ↗ EDGAR |
| 2026-03-26 | SHEPARD WILLIAM R | Director | BUY | $18K | ↗ EDGAR |
| 2026-03-17 | Marcus Jonathan L | Other | SELL 10b5-1 | $1.1M | ↗ EDGAR |
| 2026-03-17 | Marcus Jonathan L | Other | SELL 10b5-1 | $1.0M | ↗ EDGAR |
| 2026-03-12 | Vroman Ken | C-suite | SELL | $1.6M | ↗ EDGAR |
| 2026-03-06 | Cook Elizabeth A | Director | SELL | $320K | ↗ EDGAR |
| 2026-02-23 | Durkin Bryan T | Director | SELL | $1.3M | ↗ EDGAR |
| 2026-02-20 | GEPSMAN MARTIN J | Director | SELL | $92K | ↗ EDGAR |
| 2026-02-06 | Suskind Dennis | Director | SELL | $224K | ↗ EDGAR |
| 2025-12-30 | SHEPARD WILLIAM R | Director | BUY | $3K | ↗ EDGAR |
| 2025-12-30 | SHEPARD WILLIAM R | Director | BUY | $70K | ↗ EDGAR |
| 2025-12-11 | DUFFY TERRENCE A | C-suite | SELL | $3.5M | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| ◆ insider | 2026-11-02 | Winkler Julie C-suite | SELL | $3.1M |
| ◆ insider | 2026-11-02 | SIEGEL HOWARD J Director | SELL | $606K |
| ◆ insider | 2026-10-27 | Cutinho Sunil C-suite | SELL | $1.5M |
| ◆ insider | 2026-10-22 | GEPSMAN MARTIN J Director | SELL | $121K |
| ◆ insider | 2026-09-25 | SHEPARD WILLIAM R Director | BUY | $79K |
| ◆ insider | 2026-09-14 | Cook Elizabeth A Director | SELL | $140K |
| ◆ insider | 2026-09-10 | DUFFY TERRENCE A C-suite | SELL | $3.9M |
| ◆ insider | 2026-09-10 | DUFFY TERRENCE A C-suite | SELL | $173K |
| ◆ insider | 2026-06-25 | SHEPARD WILLIAM R Director | BUY | $3K |
| ◆ insider | 2026-06-25 | SHEPARD WILLIAM R Director | BUY | $75K |
| Congress | 2026-06-16 | Gilbert Cisneros | SELL | $1K–$15K |
| ◆ insider | 2026-05-18 | Piell Hilda Harris C-suite | SELL | $1.8M |
| ◆ insider | 2026-05-15 | DUFFY TERRENCE A C-suite | SELL | $7.8M |
| ◆ insider | 2026-05-15 | DUFFY TERRENCE A C-suite | SELL | $2.7M |
| Congress | 2026-03-27 | Alan Armstrong | BUY | $1K–$15K |
| ◆ insider | 2026-03-26 | SHEPARD WILLIAM R Director | BUY | $419K |
| ◆ insider | 2026-03-26 | SHEPARD WILLIAM R Director | BUY | $18K |
| ◆ insider | 2026-03-17 | Marcus Jonathan L Other 10b5-1 | SELL | $1.1M |
| ◆ insider | 2026-03-17 | Marcus Jonathan L Other 10b5-1 | SELL | $1.0M |
| ◆ insider | 2026-03-12 | Vroman Ken C-suite | SELL | $1.6M |
| ◆ insider | 2026-03-06 | Cook Elizabeth A Director | SELL | $320K |
| ◆ insider | 2026-02-23 | Durkin Bryan T Director | SELL | $1.3M |
| ◆ insider | 2026-02-20 | GEPSMAN MARTIN J Director | SELL | $92K |
| ◆ insider | 2026-02-06 | Suskind Dennis Director | SELL | $224K |
FAQ Common questions
How much has Congress traded CME?
29 disclosed buys and 25 sells of CME (Cme Group Inc.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade CME?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.